Feldman A M, Levine M A, Baughman K L, Van Dop C
Biochem Biophys Res Commun. 1987 Feb 13;142(3):631-7. doi: 10.1016/0006-291x(87)91461-6.
NAD+ significantly enhances adenylate cyclase activity in crude cardiac membrane preparations. This increase is dose-dependent, does not occur in the presence of nicotinamide, ADP-ribose or NADP+, and can be effected by a 30 min pre-incubation period with NAD+. Time course studies are consistent with an enzymatically mediated modification that used NAD+ as substrate. Furthermore, inhibition of NAD+-mediated activation by arginine suggests that this modulation of cardiac adenylate cyclase is analogous to that catalyzed by endogenous ADP-ribosyl transferases.
NAD+可显著增强粗制心脏膜制剂中的腺苷酸环化酶活性。这种增强呈剂量依赖性,在烟酰胺、ADP-核糖或NADP+存在时不会发生,且在与NAD+预孵育30分钟后即可实现。时间进程研究结果与以NAD+为底物的酶促介导修饰相一致。此外,精氨酸对NAD+介导的激活作用的抑制表明,心脏腺苷酸环化酶的这种调节作用类似于内源性ADP-核糖基转移酶所催化的调节作用。